Immunogenicity results using human papillomavirus (HPV) specific DNA vaccine, INO-3112 (HPV16/HPV18 plasmids + IL-12) in HPV+ head and neck squamous cell carcinoma (HNSCCa).

Charu Aggarwal,Roger B. Cohen,Matthew P. Morrow,Kimberly A. Kraynyak,Joshua Bauml,Gregory S. Weinstein,Jean D. Boyer,Jian Yan,Drishty Mangrolia,Sandra Oyola,Susan Duff,David B. Weiner,Ildiko Csiki,Mark L. Bagarazzi

Immunogenicity results using human papillomavirus (HPV) specific DNA vaccine, INO-3112 (HPV16/HPV18 plasmids + IL-12) in HPV+ head and neck squamous cell carcinoma (HNSCCa).

2017

Charu Aggarwal
Roger B. Cohen
Matthew P. Morrow
Kimberly A. Kraynyak
Joshua Bauml
Gregory S. Weinstein
Jean D. Boyer
Jian Yan
Drishty Mangrolia
Sandra Oyola
Susan Duff
David B. Weiner
Ildiko Csiki
Mark L. Bagarazzi

6073Background: Oropharyngeal HNSCCa is frequently associated with HPV. We hypothesize that immunotherapy with INO-3112 will generate immune responses in patients (pts) with HPV+ HNSCCa. Methods: T...

Keywords:

Plasmid
Cancer research
Immunogenicity
Head and neck squamous-cell carcinoma
Pathology
DNA vaccination
Interleukin 12
Medicine
Immunotherapy
Immune system
human papillomavirus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations